wawang anwarudin 2026. Cost-Effectiveness Analysis of Rifampicin and Bedaquiline Use for Tuberculosis Treatment: A Systematic Review. Journal of Health Economic and Policy Research (JHEPR). 4, 1 (Apr. 2026), 95–103. DOI:https://doi.org/10.30595/jhepr.v4i1.442.